Ryvu Therapeutics S.A. (WSE: RVU)
Poland
· Delayed Price · Currency is PLN
43.60
-1.45 (-3.22%)
Nov 20, 2024, 5:00 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 1.01 billion as of November 21, 2024. Its market cap has decreased by -23.10% in one year.
Market Cap
1.01B
Enterprise Value
841.43M
Revenue
91.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.60
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 1.01B, an increase of 1,684.04%. That is a compound annual growth rate of 24.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Krka, d. d. | 18.44B |
NEUCA S.A. | 3.47B |
Sopharma AD | 2.12B |
Synektik Spólka Akcyjna | 1.47B |
Celon Pharma S.A. | 1.39B |
Voxel S.A. | 1.20B |
Selvita S.A. | 941.64M |
Centrum Medyczne ENEL-MED S.A. | 565.61M |